logo
Plus   Neg
Share
Email

Allergan: FDA Approves BOTOX For Pediatric Patients With Upper Limb Spasticity

Allergan plc (AGN) announced U.S. FDA approval of the company's sBLA for BOTOX for the treatment of pediatric patients with upper limb spasticity. BOTOX is the First Neurotoxin treatment approved to treat patients of, 2 to 17 years of age, for the therapeutic Indication. The approval was based on data from two Phase 3 studies evaluating BOTOX in over 200 pediatric patients.

The company's additional sBLA for the use of BOTOX to treat pediatric patients with lower limb spasticity, is currently under FDA review, and a decision is expected in the fourth quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health Corp. is hiring 15,000 employees across the U.S. in the fourth quarter to better equip them to tackle the anticipated rise in COVID-19 and flu incidences during the fall and winter months. This is in addition to the recruitment announced in March to fill 50,000 new full-time, part-time and temporary roles across the country in support of the company's response to the pandemic. Ireland's Data Protection Commissioner or DPC, the European Union's main data privacy regulator, is investigating Facebook over its handling of millions of children's personal data on Instagram, reports said. The agency has started two separate inquiries regarding information that email addresses and phone numbers of users under 18 were made public by the Facebook-owned app. ConocoPhillips (COP) and Concho Resources (CXO) announced Monday that they have entered into a definitive agreement to combine companies in an all-stock transaction valued at $9.7 billion. The transaction creates a company with an approximately $60 billion enterprise value and a combined resource...
Follow RTT